Effects of Exogenous Glucagon-Like Peptide-1 on the Blood Pressure, Heart Rate, Mesenteric Blood Flow, and Glycemic Responses to Intraduodenal Glucose in Healthy Older Subjects
Context:Studies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated between fasting and postprandial, blood pressure (BP) and heart rate (HR).Objective:To determine whether exogenous GLP-1 modulates the effec...
Saved in:
Published in | The journal of clinical endocrinology and metabolism Vol. 99; no. 12; pp. E2628 - E2634 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Oxford University Press
01.12.2014
Copyright by The Endocrine Society |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Context:Studies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated between fasting and postprandial, blood pressure (BP) and heart rate (HR).Objective:To determine whether exogenous GLP-1 modulates the effects of an intraduodenal (ID) glucose infusion on BP, HR, and splanchnic blood flow in healthy older subjects.Design:A double-blind randomized trial was conducted.Setting:Community-dwelling residents attended a clinical research laboratory.Patients:Ten healthy “older” subjects (9 male, 1 female; age 73.2 ± 1.5 y) were studied.Interventions:Intravenous infusion of GLP-1 (0.9 pmol/kg/min), or saline (0.9%) for 90 min (t = −30–60 min). Between t = 0–60 min, ID glucose was infused at 3 kcal/min.Main Outcome Measures:BP, HR, superior mesenteric artery (SMA) flow, blood glucose, and serum insulin were measured.Results:During the fasting period (t = −30–0 min), GLP-1 had no effect on BP or HR. In response to ID glucose (t = 0–60 min), systolic BP decreased (P < .001), and both HR (P < .001) and SMA flow (P < .05) increased, on both days. GLP-1 attenuated the maximum decrease in systolic BP (P < .05), tended to increase HR (P = .09), and increased SMA flow (P < .01). GLP-1 diminished the glycemic response (P < .05).Conclusions:In healthy older subjects, acute administration of GLP-1 attenuates the hypotensive response to ID glucose, and potentiates the increase in SMA flow. |
---|---|
AbstractList | Studies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated between fasting and postprandial, blood pressure (BP) and heart rate (HR).CONTEXTStudies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated between fasting and postprandial, blood pressure (BP) and heart rate (HR).To determine whether exogenous GLP-1 modulates the effects of an intraduodenal (ID) glucose infusion on BP, HR, and splanchnic blood flow in healthy older subjects.OBJECTIVETo determine whether exogenous GLP-1 modulates the effects of an intraduodenal (ID) glucose infusion on BP, HR, and splanchnic blood flow in healthy older subjects.A double-blind randomized trial was conducted.DESIGNA double-blind randomized trial was conducted.Community-dwelling residents attended a clinical research laboratory.SETTINGCommunity-dwelling residents attended a clinical research laboratory.Ten healthy "older" subjects (9 male, 1 female; age 73.2 ± 1.5 y) were studied.PATIENTSTen healthy "older" subjects (9 male, 1 female; age 73.2 ± 1.5 y) were studied.Intravenous infusion of GLP-1 (0.9 pmol/kg/min), or saline (0.9%) for 90 min (t = -30-60 min). Between t = 0-60 min, ID glucose was infused at 3 kcal/min.INTERVENTIONSIntravenous infusion of GLP-1 (0.9 pmol/kg/min), or saline (0.9%) for 90 min (t = -30-60 min). Between t = 0-60 min, ID glucose was infused at 3 kcal/min.BP, HR, superior mesenteric artery (SMA) flow, blood glucose, and serum insulin were measured.MAIN OUTCOME MEASURESBP, HR, superior mesenteric artery (SMA) flow, blood glucose, and serum insulin were measured.During the fasting period (t = -30-0 min), GLP-1 had no effect on BP or HR. In response to ID glucose (t = 0-60 min), systolic BP decreased (P < .001), and both HR (P < .001) and SMA flow (P < .05) increased, on both days. GLP-1 attenuated the maximum decrease in systolic BP (P < .05), tended to increase HR (P = .09), and increased SMA flow (P < .01). GLP-1 diminished the glycemic response (P < .05).RESULTSDuring the fasting period (t = -30-0 min), GLP-1 had no effect on BP or HR. In response to ID glucose (t = 0-60 min), systolic BP decreased (P < .001), and both HR (P < .001) and SMA flow (P < .05) increased, on both days. GLP-1 attenuated the maximum decrease in systolic BP (P < .05), tended to increase HR (P = .09), and increased SMA flow (P < .01). GLP-1 diminished the glycemic response (P < .05).In healthy older subjects, acute administration of GLP-1 attenuates the hypotensive response to ID glucose, and potentiates the increase in SMA flow.CONCLUSIONSIn healthy older subjects, acute administration of GLP-1 attenuates the hypotensive response to ID glucose, and potentiates the increase in SMA flow. Studies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated between fasting and postprandial, blood pressure (BP) and heart rate (HR). To determine whether exogenous GLP-1 modulates the effects of an intraduodenal (ID) glucose infusion on BP, HR, and splanchnic blood flow in healthy older subjects. A double-blind randomized trial was conducted. Community-dwelling residents attended a clinical research laboratory. Ten healthy "older" subjects (9 male, 1 female; age 73.2 ± 1.5 y) were studied. Intravenous infusion of GLP-1 (0.9 pmol/kg/min), or saline (0.9%) for 90 min (t = -30-60 min). Between t = 0-60 min, ID glucose was infused at 3 kcal/min. BP, HR, superior mesenteric artery (SMA) flow, blood glucose, and serum insulin were measured. During the fasting period (t = -30-0 min), GLP-1 had no effect on BP or HR. In response to ID glucose (t = 0-60 min), systolic BP decreased (P < .001), and both HR (P < .001) and SMA flow (P < .05) increased, on both days. GLP-1 attenuated the maximum decrease in systolic BP (P < .05), tended to increase HR (P = .09), and increased SMA flow (P < .01). GLP-1 diminished the glycemic response (P < .05). In healthy older subjects, acute administration of GLP-1 attenuates the hypotensive response to ID glucose, and potentiates the increase in SMA flow. Context:Studies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated between fasting and postprandial, blood pressure (BP) and heart rate (HR).Objective:To determine whether exogenous GLP-1 modulates the effects of an intraduodenal (ID) glucose infusion on BP, HR, and splanchnic blood flow in healthy older subjects.Design:A double-blind randomized trial was conducted.Setting:Community-dwelling residents attended a clinical research laboratory.Patients:Ten healthy “older” subjects (9 male, 1 female; age 73.2 ± 1.5 y) were studied.Interventions:Intravenous infusion of GLP-1 (0.9 pmol/kg/min), or saline (0.9%) for 90 min (t = −30–60 min). Between t = 0–60 min, ID glucose was infused at 3 kcal/min.Main Outcome Measures:BP, HR, superior mesenteric artery (SMA) flow, blood glucose, and serum insulin were measured.Results:During the fasting period (t = −30–0 min), GLP-1 had no effect on BP or HR. In response to ID glucose (t = 0–60 min), systolic BP decreased (P < .001), and both HR (P < .001) and SMA flow (P < .05) increased, on both days. GLP-1 attenuated the maximum decrease in systolic BP (P < .05), tended to increase HR (P = .09), and increased SMA flow (P < .01). GLP-1 diminished the glycemic response (P < .05).Conclusions:In healthy older subjects, acute administration of GLP-1 attenuates the hypotensive response to ID glucose, and potentiates the increase in SMA flow. CONTEXT:Studies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated between fasting and postprandial, blood pressure (BP) and heart rate (HR). OBJECTIVE:To determine whether exogenous GLP-1 modulates the effects of an intraduodenal (ID) glucose infusion on BP, HR, and splanchnic blood flow in healthy older subjects. DESIGN:A double-blind randomized trial was conducted. SETTING:Community-dwelling residents attended a clinical research laboratory. PATIENTS:Ten healthy “older” subjects (9 male, 1 female; age 73.2 ± 1.5 y) were studied. INTERVENTIONS:Intravenous infusion of GLP-1 (0.9 pmol/kg/min), or saline (0.9%) for 90 min (t = −30–60 min). Between t = 0–60 min, ID glucose was infused at 3 kcal/min. MAIN OUTCOME MEASURES:BP, HR, superior mesenteric artery (SMA) flow, blood glucose, and serum insulin were measured. RESULTS:During the fasting period (t = −30–0 min), GLP-1 had no effect on BP or HR. In response to ID glucose (t = 0–60 min), systolic BP decreased (P < .001), and both HR (P < .001) and SMA flow (P < .05) increased, on both days. GLP-1 attenuated the maximum decrease in systolic BP (P < .05), tended to increase HR (P = .09), and increased SMA flow (P < .01). GLP-1 diminished the glycemic response (P < .05). CONCLUSIONS:In healthy older subjects, acute administration of GLP-1 attenuates the hypotensive response to ID glucose, and potentiates the increase in SMA flow. |
Author | Rayner, Christopher K. Jones, Karen L. Horowitz, Michael Hausken, Trygve Trahair, Laurence G. Feinle-Bisset, Christine |
AuthorAffiliation | Discipline of Medicine (L.G.T., M.H., C.F.-B., C.K.R., K.L.J.), The University of Adelaide, Adelaide 5005, Australia; National Health and Medical Research Council Centre of Research Excellence in Translating Nutritional Science to Good Health (L.G.T., M.H., C.F.-B., C.K.R., K.L.J.), The University of Adelaide, Adelaide 5005, Australia; and Section for Gastroenterology (T.H.), Department of Clinical Medicine, University of Bergen, N-5020 Bergen, Norway |
AuthorAffiliation_xml | – name: Discipline of Medicine (L.G.T., M.H., C.F.-B., C.K.R., K.L.J.), The University of Adelaide, Adelaide 5005, Australia; National Health and Medical Research Council Centre of Research Excellence in Translating Nutritional Science to Good Health (L.G.T., M.H., C.F.-B., C.K.R., K.L.J.), The University of Adelaide, Adelaide 5005, Australia; and Section for Gastroenterology (T.H.), Department of Clinical Medicine, University of Bergen, N-5020 Bergen, Norway |
Author_xml | – sequence: 1 givenname: Laurence G. surname: Trahair fullname: Trahair, Laurence G. organization: 1Discipline of Medicine (L.G.T., M.H., C.F.-B., C.K.R., K.L.J.), The University of Adelaide, Adelaide 5005, Australia – sequence: 2 givenname: Michael surname: Horowitz fullname: Horowitz, Michael organization: 1Discipline of Medicine (L.G.T., M.H., C.F.-B., C.K.R., K.L.J.), The University of Adelaide, Adelaide 5005, Australia – sequence: 3 givenname: Trygve surname: Hausken fullname: Hausken, Trygve organization: 3Section for Gastroenterology (T.H.), Department of Clinical Medicine, University of Bergen, N-5020 Bergen, Norway – sequence: 4 givenname: Christine surname: Feinle-Bisset fullname: Feinle-Bisset, Christine organization: 1Discipline of Medicine (L.G.T., M.H., C.F.-B., C.K.R., K.L.J.), The University of Adelaide, Adelaide 5005, Australia – sequence: 5 givenname: Christopher K. surname: Rayner fullname: Rayner, Christopher K. organization: 1Discipline of Medicine (L.G.T., M.H., C.F.-B., C.K.R., K.L.J.), The University of Adelaide, Adelaide 5005, Australia – sequence: 6 givenname: Karen L. surname: Jones fullname: Jones, Karen L. email: karen.jones@adelaide.edu.au organization: 1Discipline of Medicine (L.G.T., M.H., C.F.-B., C.K.R., K.L.J.), The University of Adelaide, Adelaide 5005, Australia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25210879$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ks1v2yAYxq2p05p2u-08Ie2wHeKOLxv7uFXph5SpVbdJuyGMXzdOCWSAleW_6p9YnKSXSkVCgPg9D_A-nGRH1lnIso8EnxFK8LelPqOY8JxyUbzJJqTmRS5ILY6yCcaU5LWgf4-zkxCWOGG8YO-yY1okZSXqSfY46zrQMSDXodl_dw_WDQFdmkGre2fzef8A6BbWsW8hJ8hZFBeAfhjnWnTrIYTBwxRdgfIR3amY5j8hgI3ge33ALozbTJGybXLdaliljTsIa2cDBBQdurbRq3ZwLVhldie7AKi3o6uJiy26MS149GtoluNF32dvO2UCfDiMp9mfi9nv86t8fnN5ff59nmteUpaLRgmoRFdUXdPQTou21liVqsWFqKFklSiBdZimKjQa6rorGTCOldCYNYAJO82-7n3X3v0bIES56oMGY5SFVCJJSsapqElVJPTzC3TpBp9eEyQjJeclpkwk6tOBGpoVtHLt-5XyW_mcRQLoHtDeheChk7qPKvZuLFBvJMFyDFwutRwDl2PgSTR9IXr2fQXne3zjTAopPJhhA14udqWWODVeiiofBYSmVZ66YEn2ZS9zw_q1A3YfkD0BlsvHyQ |
CitedBy_id | crossref_primary_10_1007_s11906_015_0621_6 crossref_primary_10_1186_s12933_016_0490_6 crossref_primary_10_3390_nu13082826 crossref_primary_10_1111_dom_15529 crossref_primary_10_14814_phy2_13073 crossref_primary_10_1111_bcp_12843 crossref_primary_10_3390_nu11112666 crossref_primary_10_2337_db15_0893 crossref_primary_10_1007_s00125_015_3638_0 crossref_primary_10_1186_s12877_019_1251_7 crossref_primary_10_14814_phy2_13102 crossref_primary_10_1210_clinem_dgaa341 crossref_primary_10_2337_db16_0762 crossref_primary_10_1111_dom_13864 crossref_primary_10_1177_1479164116666761 crossref_primary_10_3390_ph13110410 crossref_primary_10_3389_fnut_2020_582314 crossref_primary_10_1097_MBP_0000000000000450 crossref_primary_10_1007_s11695_015_1722_7 crossref_primary_10_1136_gutjnl_2015_310572 crossref_primary_10_1530_EC_18_0234 crossref_primary_10_1111_dom_15631 crossref_primary_10_3390_nu11081717 crossref_primary_10_1111_dom_13633 crossref_primary_10_1111_apha_12604 crossref_primary_10_2337_dc16_2391 crossref_primary_10_3390_nu17030479 crossref_primary_10_1016_j_diabres_2016_12_011 crossref_primary_10_1530_EJE_16_0507 crossref_primary_10_1161_HYPERTENSIONAHA_117_10740 crossref_primary_10_2337_dc16_0351 |
Cites_doi | 10.7326/0003-4819-122-4-199502150-00009 10.1111/j.1532-5415.1997.tb05965.x 10.1210/jc.2009-1503 10.1042/cs0950719 10.1210/er.2011-1052 10.1007/s12325-010-0110-x 10.1038/nm.3128 10.1172/JCI0215595 10.1210/jc.2011-2583 10.1152/ajpregu.00732.2004 10.1053/ejvs.2001.1313 10.1373/clinchem.2005.057638 10.2337/db10-0474 10.1152/ajpheart.00930.2009 10.1152/ajpregu.00464.2011 10.1152/ajpregu.00235.2010 10.1016/j.regpep.2008.07.003 10.1111/j.1475-097X.1991.tb00459.x 10.1136/bmj.285.6346.916 10.1111/j.1532-5415.1994.tb06582.x 10.1152/ajpendo.00373.2007 10.1111/j.1532-5415.2005.53415.x 10.1016/S0167-0115(03)00111-3 10.1016/j.jamda.2014.01.011 10.1152/ajpregu.00215.2009 10.1016/S0016-5085(83)80232-7 10.1161/01.CIR.0000139339.85840.DD 10.1152/ajpregu.00153.2008 10.1517/13543780902766802 10.1093/gerona/glr086 10.1152/ajpregu.00378.2010 10.1007/s12325-013-0009-4 10.1042/cs0770085 10.1161/CIRCULATIONAHA.107.739938 10.1042/CS20110270 10.1016/j.amjmed.2005.05.019 10.1016/S0167-0115(96)00113-9 |
ContentType | Journal Article |
Copyright | Copyright © 2014 by the Endocrine Society 2014 Copyright © 2014 by The Endocrine Society Copyright © 2014 by the Endocrine Society |
Copyright_xml | – notice: Copyright © 2014 by the Endocrine Society 2014 – notice: Copyright © 2014 by The Endocrine Society – notice: Copyright © 2014 by the Endocrine Society |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7T5 7TM H94 K9. 7X8 |
DOI | 10.1210/jc.2014-2475 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Immunology Abstracts Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Calcium & Calcified Tissue Abstracts Nucleic Acids Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1945-7197 |
EndPage | E2634 |
ExternalDocumentID | 25210879 10_1210_jc_2014_2475 00004678-201412000-00073 10.1210/jc.2014-2475 |
Genre | Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -~X .55 .XZ 08P 0R~ 18M 1TH 29K 2WC 34G 354 39C 4.4 48X 53G 5GY 5RS 5YH 8F7 AABZA AACZT AAIMJ AAPQZ AAPXW AARHZ AAUAY AAVAP AAWTL ABBLC ABDFA ABEJV ABGNP ABJNI ABLJU ABMNT ABNHQ ABOCM ABPMR ABPPZ ABPQP ABPTD ABQNK ABVGC ABWST ABXVV ACGFO ACGFS ACPRK ACUTJ ACYHN ADBBV ADGKP ADGZP ADHKW ADQBN ADRTK ADVEK AELWJ AEMDU AENEX AENZO AETBJ AEWNT AFCHL AFFZL AFGWE AFOFC AFRAH AFXAL AGINJ AGKRT AGQXC AGUTN AHMBA AHMMS AJEEA ALMA_UNASSIGNED_HOLDINGS APIBT ARIXL ASPBG ATGXG AVWKF AZFZN BAWUL BAYMD BCRHZ BEYMZ BSWAC BTRTY C45 CDBKE CS3 D-I DAKXR DIK E3Z EBS EJD EMOBN ENERS F5P FECEO FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 HZ~ H~9 KBUDW KOP KQ8 KSI KSN L7B M5~ MHKGH MJL N9A NLBLG NOMLY NOYVH NVLIB O9- OAUYM OBH OCB ODMLO OFXIZ OGEVE OHH OJZSN OK1 OPAEJ OVD OVIDX P2P P6G REU ROX ROZ TEORI TJX TLC TR2 TWZ VVN W8F WOQ X7M YBU YFH YHG YOC YSK ZY1 ~02 ~H1 .GJ 3O- 7X7 88E 8FI 8FJ AAJQQ AAKAS AAPGJ AAQQT AAUQX AAWDT AAYJJ ABDPE ABUWG ABXZS ACFRR ACVCV ACZBC ADMTO ADNBA ADZCM AEMQT AEOTA AERZD AFFNX AFFQV AFKRA AFYAG AGMDO AGORE AHGBF AI. AJBYB AJDVS ALXQX APJGH AQDSO AQKUS AVNTJ BENPR BPHCQ BVXVI CCPQU EIHJH FEDTE FYUFA HMCUK HVGLF IAO IHR INH ITC J5H M1P MBLQV N4W NU- OBFPC PHGZM PHGZT PQQKQ PROAC PSQYO TMA UKHRP VH1 WHG X52 ZGI ZXP AAYXX CITATION CGR CUY CVF ECM EIF NPM PJZUB PPXIY 7QP 7T5 7TM H94 K9. 7X8 |
ID | FETCH-LOGICAL-c4623-7ba7e87f58fbb2fc7d9c0a6ad0579e63876e3f02087bce99f63e340a7c03be013 |
ISSN | 0021-972X 1945-7197 |
IngestDate | Fri Jul 11 03:23:23 EDT 2025 Mon Jun 30 12:41:17 EDT 2025 Mon Jul 21 05:37:07 EDT 2025 Thu Apr 24 23:09:29 EDT 2025 Tue Jul 01 01:10:34 EDT 2025 Fri May 16 03:43:27 EDT 2025 Fri Feb 07 10:35:39 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4623-7ba7e87f58fbb2fc7d9c0a6ad0579e63876e3f02087bce99f63e340a7c03be013 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
PMID | 25210879 |
PQID | 3164460237 |
PQPubID | 2046206 |
ParticipantIDs | proquest_miscellaneous_1634279185 proquest_journals_3164460237 pubmed_primary_25210879 crossref_citationtrail_10_1210_jc_2014_2475 crossref_primary_10_1210_jc_2014_2475 wolterskluwer_health_00004678-201412000-00073 oup_primary_10_1210_jc_2014-2475 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20141201 2014-December 2014-12-01 2014-Dec |
PublicationDateYYYYMMDD | 2014-12-01 |
PublicationDate_xml | – month: 12 year: 2014 text: 20141201 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Washington |
PublicationTitle | The journal of clinical endocrinology and metabolism |
PublicationTitleAlternate | J Clin Endocrinol Metab |
PublicationYear | 2014 |
Publisher | Oxford University Press Copyright by The Endocrine Society |
Publisher_xml | – name: Oxford University Press – name: Copyright by The Endocrine Society |
References | Basu (2019041115292766600_B27) 2007; 293 Deane (2019041115292766600_B40) 2010; 95 Kim (2019041115292766600_B38) 2013; 19 Nauck (2019041115292766600_B17) 2011; 60 Brandt (2019041115292766600_B37) 2006; 52 Gentilcore (2019041115292766600_B7) 2009; 297 Horowitz (2019041115292766600_B18) 2013; 30 Trahair (2019041115292766600_B32) 2012; 97 Flint (2019041115292766600_B12) 2011; 28 Heddle (2019041115292766600_B29) 1988; 255 Brener (2019041115292766600_B9) 1983; 85 Vanis (2019041115292766600_B34) 2011; 300 Trahair (2019041115292766600_B6) 2014; 15 Piha (2019041115292766600_B30) 1991; 11 Brennan (2019041115292766600_B36) 2005; 288 Yamamoto (2019041115292766600_B23) 2002; 110 Aronow (2019041115292766600_B2) 1994; 42 Vilsbøll (2019041115292766600_B14) 2003; 114 Edwards (2019041115292766600_B24) 1998; 95 Jansen (2019041115292766600_B1) 1995; 122 Aronow (2019041115292766600_B4) 1997; 45 Linnebjerg (2019041115292766600_B35) 2008; 151 Fisher (2019041115292766600_B5) 2005; 53 Vanis (2019041115292766600_B11) 2012; 302 Malone (2019041115292766600_B13) 2009; 18 Trahair (2019041115292766600_B10) 2012; 122 Gentilcore (2019041115292766600_B19) 2005; 118 Vanis (2019041115292766600_B8) 2010; 299 Ussher (2019041115292766600_B21) 2012; 33 Halbirk (2019041115292766600_B25) 2010; 298 Perko (2019041115292766600_B31) 2001; 21 Nauck (2019041115292766600_B15) 1997; 273 Willms (2019041115292766600_B16) 1996; 81 Ewing (2019041115292766600_B33) 1982; 285 Bharucha (2019041115292766600_B26) 2008; 295 Barragán (2019041115292766600_B22) 1996; 67 Ban (2019041115292766600_B28) 2008; 117 Gentilcore (2019041115292766600_B20) 2011; 66 Nikolaidis (2019041115292766600_B39) 2004; 110 Mathias (2019041115292766600_B3) 1989; 77 |
References_xml | – volume: 122 start-page: 286 year: 1995 ident: 2019041115292766600_B1 article-title: Postprandial hypotension: Epidemiology, pathophysiology, and clinical management publication-title: Ann Intern Med doi: 10.7326/0003-4819-122-4-199502150-00009 – volume: 45 start-page: 1051 year: 1997 ident: 2019041115292766600_B4 article-title: Association of postprandial hypotension with incidence of falls, syncope, coronary events, stroke, and total mortality at 29-month follow-up in 499 older nursing home residents publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.1997.tb05965.x – volume: 95 start-page: 215 year: 2010 ident: 2019041115292766600_B40 article-title: Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2009-1503 – volume: 95 start-page: 719 year: 1998 ident: 2019041115292766600_B24 article-title: Subcutaneous glucagon-like peptide-1 (7–36) amide is insulinotropic and can cause hypoglycaemia in fasted healthy subjects publication-title: Clin Sci (Lond) doi: 10.1042/cs0950719 – volume: 33 start-page: 187 year: 2012 ident: 2019041115292766600_B21 article-title: Cardiovascular biology of the incretin system publication-title: Endocr Rev doi: 10.1210/er.2011-1052 – volume: 28 start-page: 213 year: 2011 ident: 2019041115292766600_B12 article-title: The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients publication-title: Adv Ther doi: 10.1007/s12325-010-0110-x – volume: 19 start-page: 567 year: 2013 ident: 2019041115292766600_B38 article-title: GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure publication-title: Nat Med doi: 10.1038/nm.3128 – volume: 110 start-page: 43 year: 2002 ident: 2019041115292766600_B23 article-title: Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons publication-title: J Clin Invest doi: 10.1172/JCI0215595 – volume: 97 start-page: 844 year: 2012 ident: 2019041115292766600_B32 article-title: Comparative effects of variations in duodenal glucose load on glycemic, insulinemic, and incretin responses in healthy young and older subjects publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2011-2583 – volume: 288 start-page: R1477 year: 2005 ident: 2019041115292766600_B36 article-title: Evaluation of interactions between CCK and GLP-1 in their effects on appetite, energy intake, and antropyloroduodenal motility in healthy men publication-title: Am J Physiol Regul Integr Comp Physiol doi: 10.1152/ajpregu.00732.2004 – volume: 21 start-page: 106 year: 2001 ident: 2019041115292766600_B31 article-title: Duplex ultrasound for assessment of superior mesenteric artery blood flow publication-title: Eur J Vasc Endovasc Surg doi: 10.1053/ejvs.2001.1313 – volume: 52 start-page: 82 year: 2006 ident: 2019041115292766600_B37 article-title: Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form publication-title: Clin Chem doi: 10.1373/clinchem.2005.057638 – volume: 60 start-page: 1561 year: 2011 ident: 2019041115292766600_B17 article-title: Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans publication-title: Diabetes doi: 10.2337/db10-0474 – volume: 298 start-page: H1096 year: 2010 ident: 2019041115292766600_B25 article-title: Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00930.2009 – volume: 302 start-page: R391 year: 2012 ident: 2019041115292766600_B11 article-title: Effects of variations in intragastric volume on blood pressure and splanchnic blood flow during intraduodenal glucose infusion in healthy older subjects publication-title: Am J Physiol Regul Integr Comp Physiol doi: 10.1152/ajpregu.00464.2011 – volume: 299 start-page: R960 year: 2010 ident: 2019041115292766600_B8 article-title: Effects of gastric distension on blood pressure and superior mesenteric artery blood flow responses to intraduodenal glucose in healthy older subjects publication-title: Am J Physiol Regul Integr Comp Physiol doi: 10.1152/ajpregu.00235.2010 – volume: 273 start-page: E981 year: 1997 ident: 2019041115292766600_B15 article-title: Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans publication-title: Am J Physiol – volume: 151 start-page: 123 year: 2008 ident: 2019041115292766600_B35 article-title: Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes publication-title: Regul Pept doi: 10.1016/j.regpep.2008.07.003 – volume: 11 start-page: 277 year: 1991 ident: 2019041115292766600_B30 article-title: Cardiovascular autonomic reflex tests: Normal responses and age-related reference values publication-title: Clin Physiol doi: 10.1111/j.1475-097X.1991.tb00459.x – volume: 81 start-page: 327 year: 1996 ident: 2019041115292766600_B16 article-title: Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: Effects of exogenous glucagon-like peptide-1 (GLP-1)-(7–36) amide in type 2 (noninsulin-dependent) diabetic patients publication-title: J Clin Endocrinol Metab – volume: 285 start-page: 916 year: 1982 ident: 2019041115292766600_B33 article-title: Diagnosis and management of diabetic autonomic neuropathy publication-title: Br Med J (Clin Res Ed) doi: 10.1136/bmj.285.6346.916 – volume: 42 start-page: 930 year: 1994 ident: 2019041115292766600_B2 article-title: Postprandial hypotension in 499 elderly persons in a long-term health care facility publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.1994.tb06582.x – volume: 293 start-page: E1289 year: 2007 ident: 2019041115292766600_B27 article-title: Beneficial effects of GLP-1 on endothelial function in humans: Dampening by glyburide but not by glimepiride publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00373.2007 – volume: 53 start-page: 1313 year: 2005 ident: 2019041115292766600_B5 article-title: Postprandial hypotension predicts all-cause mortality in older, low-level care residents publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2005.53415.x – volume: 114 start-page: 115 year: 2003 ident: 2019041115292766600_B14 article-title: Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects publication-title: Regul Pept doi: 10.1016/S0167-0115(03)00111-3 – volume: 15 start-page: 394 year: 2014 ident: 2019041115292766600_B6 article-title: Postprandial Hypotension: A Systematic Review publication-title: J Am Med Dir Assoc doi: 10.1016/j.jamda.2014.01.011 – volume: 297 start-page: R716 year: 2009 ident: 2019041115292766600_B7 article-title: Comparative effects of oral and intraduodenal glucose on blood pressure, heart rate, and splanchnic blood flow in healthy older subjects publication-title: Am J Physiol Regul Integr Comp Physiol doi: 10.1152/ajpregu.00215.2009 – volume: 85 start-page: 76 year: 1983 ident: 2019041115292766600_B9 article-title: Regulation of the gastric emptying of glucose publication-title: Gastroenterology doi: 10.1016/S0016-5085(83)80232-7 – volume: 110 start-page: 955 year: 2004 ident: 2019041115292766600_B39 article-title: Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy publication-title: Circulation doi: 10.1161/01.CIR.0000139339.85840.DD – volume: 295 start-page: R874 year: 2008 ident: 2019041115292766600_B26 article-title: Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans publication-title: Am J Physiol Regul Integr Comp Physiol doi: 10.1152/ajpregu.00153.2008 – volume: 18 start-page: 359 year: 2009 ident: 2019041115292766600_B13 article-title: Exenatide once weekly for the treatment of type 2 diabetes publication-title: Expert Opin Investig Drugs doi: 10.1517/13543780902766802 – volume: 66 start-page: 917 year: 2011 ident: 2019041115292766600_B20 article-title: The alpha ([alpha])-glucosidase inhibitor, acarbose, attenuates the blood pressure and splanchnic blood flow responses to intraduodenal sucrose in older adults publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/glr086 – volume: 300 start-page: R1524 year: 2011 ident: 2019041115292766600_B34 article-title: Effects of small intestinal glucose load on blood pressure, splanchnic blood flow, glycemia, and GLP-1 release in healthy older subjects publication-title: Am J Physiol Regul Integr Comp Physiol doi: 10.1152/ajpregu.00378.2010 – volume: 30 start-page: 81 year: 2013 ident: 2019041115292766600_B18 article-title: Mechanisms and clinical efficacy of lixisenatide for the management of type 2 diabetes publication-title: Adv Ther doi: 10.1007/s12325-013-0009-4 – volume: 77 start-page: 85 year: 1989 ident: 2019041115292766600_B3 article-title: Differential blood pressure and hormonal effects after glucose and xylose ingestion in chronic autonomic failure publication-title: Clin Sci (Lond) doi: 10.1042/cs0770085 – volume: 255 start-page: G490 year: 1988 ident: 2019041115292766600_B29 article-title: Topography and measurement of pyloric pressure waves and tone in humans publication-title: Am J Physiol – volume: 117 start-page: 2340 year: 2008 ident: 2019041115292766600_B28 article-title: Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.739938 – volume: 122 start-page: 271 year: 2012 ident: 2019041115292766600_B10 article-title: Effects of variations in duodenal glucose load on blood pressure, heart rate, superior mesenteric artery blood flow and plasma noradrenaline in healthy young and older subjects publication-title: Clin Sci (Lond) doi: 10.1042/CS20110270 – volume: 118 start-page: 1289 year: 2005 ident: 2019041115292766600_B19 article-title: Acarbose attenuates the hypotensive response to sucrose and slows gastric emptying in the elderly publication-title: Am J Med doi: 10.1016/j.amjmed.2005.05.019 – volume: 67 start-page: 63 year: 1996 ident: 2019041115292766600_B22 article-title: Interactions of exendin- (9–39) with the effects of glucagon-like peptide-1-(7–36) amide and of exendin-4 on arterial blood pressure and heart rate in rats publication-title: Regul Pept doi: 10.1016/S0167-0115(96)00113-9 |
SSID | ssj0014453 |
Score | 2.3176193 |
Snippet | Context:Studies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated... CONTEXT:Studies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated... Studies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated between... |
SourceID | proquest pubmed crossref wolterskluwer oup |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | E2628 |
SubjectTerms | Aged Autonomic Nervous System - drug effects Blood flow Blood Glucose - metabolism Blood pressure Blood Pressure - drug effects Cardiovascular system Clinical trials Double-Blind Method Duodenum - metabolism Fasting Female Gastric emptying Glucagon Glucagon-like peptide 1 Glucagon-Like Peptide 1 - pharmacology Glucose Glucose - administration & dosage Glucose - pharmacology Heart rate Heart Rate - drug effects Humans Insulin - blood Intubation, Gastrointestinal Male Mesenteric Arteries - drug effects Peptides Splanchnic Circulation - drug effects |
Title | Effects of Exogenous Glucagon-Like Peptide-1 on the Blood Pressure, Heart Rate, Mesenteric Blood Flow, and Glycemic Responses to Intraduodenal Glucose in Healthy Older Subjects |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004678-201412000-00073 https://www.ncbi.nlm.nih.gov/pubmed/25210879 https://www.proquest.com/docview/3164460237 https://www.proquest.com/docview/1634279185 |
Volume | 99 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEF21RUIghIBSCBS0SPCUbBVf4o0fKeRSIICqVOqb5d1sqpBgo8ShlK_iE5nZi2NDKxVeosRZx3bmeHZmfc4MIS95Cg7ACzjjUVswrEbIUi_kLAWXKNpKyFA3mxh9jIYn4bvTzunW9m6FtbQuxIH8eamu5H-sCtvArqiS_QfLlj8KG-A92BdewcLwei0b9zZkjN6P3JZbHWAfs7M8Yx9mc9X8jKyViWKefSrQPESmulUFmvXnIYC9aB6nplHeSMuRNMHeDO0vzOMfXGEfLC6kZtMfG2qtqQ9xhAvEk3UOLgwMPrAkeF1EC8llF81P2AocfRQu-qyq8TCitFK8otRpqmySgz_LNhWivqoC8LpwFQ9xsQFF3rOlU3drFzU4KHGaL_Pzme5WW9MGaG-7Xs2Nux0vL86-l9juq1m2UOwQOQrFpvSCox7YxREvrBBNnFjBYzHXHdthujM-Pg47jHuGFuwmAdOlyYHdr7j0nh9Z-bpyn83y61-TD2TPOPlgYUw4Ez80LWHqNb7_mHtLRiTmYrB_8kUmuHeCe2-TGz4kP9iX4-3R-_LZWBja2qr20qycA7VY1WPXAq2aeLOSQ90md85zpGWs5lqVUYmtxvfIXZsU0dcG4ffJlsoekJsjS_vYJb8s0Gk-pSXQaQ3otAQ6zTMKQKcavdQBvUU1zCnCvEU3ILfDEOQtCjijDuK0hDgtclqDOLUQp7OMWohTDXHqIP6QnPR74zdDZluNMBlCAsC4SLnq8mmnOxXCn0o-iWU7jdIJarUVzFE8UsEUG9pyIVUcT6NABWE75bIdCAVp1B7ZyfJMPSa0K2IBcXHajmQUSl8K7ndlV4gueD4F6U2DNJ1dEmnr8GM7mEVyGQYa5FU5-pupP3PFOAomvmoIM0P2nf0Te2evksCDhCiCwJ03yIvya5hi8LlhmikwZwIpW-jzGCL7BnlkcFMeyIfwH_6UuEFYDUiJkXEneg0CAmKGp-G5OhY8eHLN63pKbm3u632yUyzX6hmkAYV4ru-K37r8Btc |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+Exogenous+Glucagon-Like+Peptide-1+on+the+Blood+Pressure%2C+Heart+Rate%2C+Mesenteric+Blood+Flow%2C+and+Glycemic+Responses+to+Intraduodenal+Glucose+in+Healthy+Older+Subjects&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Trahair%2C+Laurence+G.&rft.au=Horowitz%2C+Michael&rft.au=Hausken%2C+Trygve&rft.au=Feinle-Bisset%2C+Christine&rft.date=2014-12-01&rft.issn=0021-972X&rft.eissn=1945-7197&rft.volume=99&rft.issue=12&rft.spage=E2628&rft.epage=E2634&rft_id=info:doi/10.1210%2Fjc.2014-2475&rft.externalDBID=n%2Fa&rft.externalDocID=10_1210_jc_2014_2475 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon |